The Medicines and Healthcare Products Regulatory Agency (MHRA) review into the safety of alteplase, the thrombolytic (clot-busting) drug for the treatment of strokes, has concluded that alteplase is “safe and effective”. The expert working group of the UK’s Commission on Human Medicines (CHM) asserts that alteplase is safe and effective for use up to 4.5 hours after the onset of symptoms.
Clot-busting stroke drug safe, says expert review. London: BBC Health News, July 24th 2015.
This relates to:
Independent expert review concludes alteplase is safe and effective for use within existing treatment guidelines. London: Medicines and Healthcare Products Regulatory Agency, July 24th 2015.